Dudediligence.

Imunon, Inc

IMNNNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

4.67M

on 2026-06-30, from 627K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-15 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

S-3 of 2024-05-15. Not read yet. S-3 ↗

6 of its filings are not read yet.

Warrants

1.00M

Warrants of every class as tagged in the XBRL facts on 2025-07-28. 10-Q ↗

Cash

1.8 quarters

$6.9M on 2026-06-30 ÷ $3.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-06-02Private placementnot read$10000.00$2.5M8-K ↗
2026-03-23Public offeringnot readnot readnot read424B5 ↗
2025-12-29Public offering incl. 1.61M pre-funded, with warrants at $3.481,939,114$3.61$7.0M424B5 ↗
2025-07-22Public offeringnot readnot readnot read424B5 ↗
2025-05-23Private placement incl. 4.44M pre-funded8,888,888not read$3.3M8-K ↗

Also on file: a 1-for-15 reverse split, 2025-07-25 8-K ↗